The State of Alzheimer’s: A Q&A with Salim Syed
In this Q&A, our Biotech Analyst Salim Syed shares his perspective on the state of Alzheimer’s, the results of a clinic trial for BAN2401, and the ups and downs of developing drugs to treat this degenerative disease.